United States Federal Circuit

The decision of the USPTO Board of Patent Appeals and Interferences granting defendant's preliminary motion to have all of the allowed claims of plaintiff's patent application for fibrinogen producing transgenic animals held unpatentable as obvious over the prior art is affirmed where it is supported by substantial evidence.

Appellate Information

• Decided 11/05/2003
• Published 11/05/2003

Judges

• Before SCHALL, GAJARSA, and PROST, Circuit Judges.

Court

• United States Federal Circuit

Counsel

• For Appellant:
  
• R. Elizabeth Brenner, Foley & Lardner, of Washington, DC, argued for appellants.   With her on the brief were Stephen A. Bent and Jack L. Lahr.


• For Appellees:
  
• James F. Haley, Jr., Fish & Neave, of New York, NY, argued for appellees.   With him on the brief was Karen Mangasarian.